StocksRunner logo
 
menu
 
 

Analysts Upgrade MSFT, CAT, GOOG and More Today, Unveiling Fresh Opportunities

 
  • user  TopRated
  •  
     
      
     
     
     

    TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.

     
 
  • like  09 Jul 2025
  •  
 
 

Canaccord Genuity lifted its price target on Atai Life Sciences to $12 while maintaining a Buy rating, signaling confidence in its psychedelic therapies pipeline. With shares trading at $2.67, the upside potential here remains meaningful for high-risk, high-reward biotech investors looking for early-stage growth.

Best Buy received a rating upgrade on improved tariff management and a constructive growth outlook. While shares are near $72, the call suggests analysts see stabilization and potential for operational upside despite macro headwinds.

TopBuild caught attention after its acquisition of Progressive Roofing, with Benchmark reiterating its Buy rating. The stock jumped 5% to $374, reflecting the market’s confidence in management’s strategic expansion in the building materials and services space.

Caterpillar received an upgrade from Melius, citing data center power potential as a growth catalyst. At $403, this industrial giant looks poised to benefit from the AI infrastructure build-out while maintaining strong cyclical leverage.

Charles River Labs saw an upgrade from Citi, focusing on DSA growth prospects. Trading at $158, the upgrade points to optimism around its contract research services amid rising biopharma demand.

Datadog joined the S&P 500, and TD Cowen reiterated its Buy rating, reflecting its continued leadership in cloud monitoring. Shares recently dipped to $142, presenting a possible entry point as large-cap flows begin to follow the index inclusion.

Citi reiterated its Buy recommendation on Devon Energy, maintaining a bullish stance despite recent weakness. At $34, the call indicates confidence in the company’s shareholder return policy and operational efficiency.

UBS kept its Buy rating on EOG Resources with a $140 price target, underscoring its strong balance sheet and disciplined capital approach, with shares currently at $121.

Enterprise Products Partners maintained its Buy rating from UBS, reflecting confidence in stable cash flows and yield for income-focused investors, with shares at $31.

TD Cowen raised its price target on Genpact while maintaining a Buy rating, showing conviction in its digital transformation positioning, though the stock slipped to $45.

Alphabet saw analysts declare its growth catalysts as overly discounted, urging a “double-down” Strong Buy stance. Trading at $177, the call suggests a view that the AI and ad rebound narrative remains underappreciated.

Wolfe Research upgraded Huntington Bancshares to Outperform, citing stabilizing regional banking trends. At $17, the upgrade suggests selective optimism in the battered regional bank space.

Citi upgraded Hologic to Buy, highlighting attractive valuation and a favorable growth outlook in medical diagnostics, with shares at $65.

LiveOne rallied 4% to $0.80 after Slacker Radio partnered with Intuizi to enhance subscriber targeting, a strategic move aiming to fuel subscriber growth and engagement.

Merck retained a Buy rating from UBS, underpinned by optimism around HPV vaccine prospects. Shares rose 3% to $83, reflecting ongoing interest in its robust pipeline.

Microsoft received a string of upgrades from Oppenheimer, which noted that the AI opportunity remains underpriced. Shares at $502 still imply further upside as Wall Street re-evaluates its AI and cloud positioning.

Roku maintained a Buy rating at Needham with an upgraded price target, as its labor efficiency improvements support margin expansion. Shares at $88 show continued investor interest in its turnaround.

SharpLink Gaming was reiterated as a Buy, driven by Ethereum exposure, which analysts believe adds strategic value to its gaming operations, with shares at $16.

Seaport Global raised its price target on Synchrony Financial while maintaining a Buy rating, pointing to a solid consumer credit backdrop and attractive valuation with shares at $69.

Thermo Fisher Scientific, despite some conflicting analyst sentiment, saw support on growth stability with shares trading at $416, indicating a potential rebound for patient investors.

Westinghouse Air Brake (Wabtec) maintained its Buy rating at BofA, supported by operational execution and a raised price target. At $212, the stock continues to benefit from transport sector tailwinds.

Wingstop initiated coverage with a Buy rating, reflecting analysts' confidence in its growth trajectory and store expansion strategy, with shares rising to $333.

Warner Music was upgraded to Neutral by BofA, reflecting its cost-cutting and JV initiatives, with shares at $29 showing cautious optimism for gradual improvement in the music industry’s margin profile.

 
 

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!


Why Join?

Find out what 10,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

 
Signup to Stocksrunner
 
 
 

Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.

 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive Our Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Our Services

Real-time stock market updates

Expert stock analysis

Investment strategies

Top stock recommendations

Trading signals and opportunities

 
About StocksRunner

Log In

Sign Up

Plans & Pricinig

Contact Us

Terms of use

Privacy Policy

 
 
 
StocksRunner

Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Subscribe to Our Daily Updates

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stocks analysis

Stocks trends

Stocks performance

Stocks analysis

Investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo